The Mojaloop Foundation today announced the appointment of Jean Bosco Iyacu as Chief Executive Officer, effective June 1, 2026. He succeeds Paula Hunter, who will retire. She will transition out of the Executive Director role during the leadership handover. Based in Kigali, Rwanda, Jean Bosco brings more than 15 years of experience in inclusive financial systems, digital finance and Digital Public Infrastructure (DPI) to enable the achievement of Sustainable Development Goals (SDGs) and Marke...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its first quarter 2026 financial results on Wednesday, May 6, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com.To ensure a timely connection, it is recommended th...

Chatham Financial (“Chatham”), the leading independent capital markets advisor, helping organizations reduce risk and seize opportunity through expert advice and powerful technology, today announced it has entered into a definitive agreement to acquire Hodes Weill & Associates (“Hodes Weill”), a leading global capital advisory firm focused on real estate, infrastructure, and other real assets. The transaction combines premier global firms with highly complementary service offerings and capa...

Veristat (the “Company”), a science-first full-service CRO and consultancy that advances complex therapies through the drug development lifecycle to regulatory submission, announced today its intended acquisition of Certara’s Regulatory and Medical Writing business. The team that will join Veristat is known for its white-glove advisory services and deep expertise authoring clinical and non-clinical documents throughout the drug development lifecycle. The acquisition is supported by WindRose Hea...